IBB

iShares Biotechnology ETF · NAS

  • Category Health Care
  • Expense Ratio 0.45%
  • Listing Date
  • Volume 2,728,749.0
  • Market Cap (AUM) $5,483.43M

Performance

+5.44%

1W

-7.02%

1M

-10.08%

3M

-12.52%

6M

-5.97%

YTD

-2.52%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Amgen Inc.AMGN9.23%
  • Vertex Pharmaceuticals IncorporatedVRTX9.17%
  • Regeneron Pharmaceuticals, Inc.REGN8.88%
  • Gilead Sciences, Inc.GILD7.24%
  • Moderna, Inc.MRNA4.49%
  • IQVIA Holdings IncIQV3.84%
  • Biogen Inc.BIIB3.24%
  • Mettler-Toledo International Inc.MTD3.15%
  • Alnylam Pharmaceuticals, IncALNY1.94%
  • argenx SE ADRARGX1.91%

Technical Analysis of IBB 2025-04-24

The stock indicators reflect a neutral sentiment, with the Moving Average Score, Oscillators Score, and Technical Score all at 50, indicating a balanced market condition without strong bullish or bearish signals. This suggests that investors may be in a wait-and-see mode, as there is no clear direction in the current price action.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.